Lazzaro Spallanzani, National Institute for Infectious Diseases-IRCCS, Via Portuense, 292, Cap 00149, Rome, Italy.
UMRS 1134, Inserm, Université de Paris, 75015, Paris, France.
Malar J. 2021 Apr 29;20(1):206. doi: 10.1186/s12936-021-03735-w.
Post-artesunate delayed haemolysis (PADH) is common after severe malaria episodes. PADH is related to the "pitting" phenomenon and the synchronous delayed clearance of once-infected erythrocytes, initially spared during treatment. However, direct antiglobulin test (DAT) positivity has been reported in several PADH cases, suggesting a contribution of immune-mediated erythrocyte clearance. The aim of the present study was to compare clinical features of cases presenting a positive or negative DAT.
Articles reporting clinical data of patients diagnosed with PADH, for whom DAT had been performed, were collected from PubMed database. Data retrieved from single patients were extracted and univariate analysis was performed in order to identify features potentially related to DAT results and steroids use.
Twenty-two studies reporting 39 PADH cases were included: median baseline parasitaemia was 20.8% (IQR: 11.2-30) and DAT was positive in 17 cases (45.5%). Compared to DAT-negative individuals, DAT-positive patients were older (49.5 vs 31; p = 0.01), had a higher baseline parasitaemia (27% vs 17%; p = 0.03) and were more commonly treated with systemic steroids (11 vs 3 patients, p = 0.002). Depth and kinetics of delayed anaemia were not associated with DAT positivity.
In this case series, almost half of the patients affected by PADH had a positive DAT. An obvious difference between the clinical courses of patients presenting with a positive or negative DAT was lacking. This observation suggests that DAT result may not be indicative of a pathogenic role of anti-erythrocytes antibodies in patients affected by PADH, but it may be rather a marker of immune activation.
青蒿琥酯治疗后迟发性溶血(PADH)在严重疟疾发作后很常见。PADH 与“凹陷”现象有关,即一旦感染的红细胞在治疗期间最初被“放过”而同步延迟清除。然而,几项 PADH 病例报告了直接抗球蛋白试验(DAT)阳性,提示免疫介导的红细胞清除作用。本研究旨在比较 DAT 阳性和阴性的病例的临床特征。
从 PubMed 数据库中收集了报告有 DAT 检测结果的 PADH 患者临床数据的文章。从单个人的数据中提取数据,并进行单变量分析,以确定与 DAT 结果和类固醇使用相关的潜在特征。
共纳入 22 项研究,报道了 39 例 PADH 病例:中位基线寄生虫血症为 20.8%(IQR:11.2-30),DAT 阳性 17 例(45.5%)。与 DAT 阴性患者相比,DAT 阳性患者年龄较大(49.5 岁 vs 31 岁;p=0.01),基线寄生虫血症较高(27% vs 17%;p=0.03),更常接受全身类固醇治疗(11 例 vs 3 例,p=0.002)。延迟性贫血的深度和动力学与 DAT 阳性无关。
在本病例系列中,几乎一半的 PADH 患者 DAT 阳性。DAT 阳性和阴性患者的临床病程明显不同。这一观察结果表明,DAT 结果可能不能说明抗红细胞抗体在 PADH 患者中的致病作用,而可能是免疫激活的标志物。